161 related articles for article (PubMed ID: 2827000)
1. Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin.
Morrison WJ; Shukla SD
Mol Pharmacol; 1988 Jan; 33(1):58-63. PubMed ID: 2827000
[TBL] [Abstract][Full Text] [Related]
2. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
Shukla SD; Morrison WJ; Dhar A
Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
Dhar A; Paul AK; Shukla SD
Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Morrison WJ; Shukla SD
J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
[TBL] [Abstract][Full Text] [Related]
5. Activation of phospholipase C in platelets by platelet activating factor and thrombin causes hydrolysis of a common pool of phosphatidylinositol 4,5-bisphosphate.
Shukla SD; Franklin CC; Carter MG
Biochim Biophys Acta; 1987 Jul; 929(2):134-41. PubMed ID: 3036249
[TBL] [Abstract][Full Text] [Related]
6. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
Burgers JA; Akkerman JW
J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
[TBL] [Abstract][Full Text] [Related]
7. Role of guanine nucleotide-binding protein and tyrosine kinase in platelet-activating factor activation of phospholipase C in A431 cells: proposal for dual mechanisms.
Thurston AW; Rhee SG; Shukla SD
J Pharmacol Exp Ther; 1993 Aug; 266(2):1106-12. PubMed ID: 7689100
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of phospholipase C concomitant with its activation by platelet-activating factor in a human B cell line.
Kuruvilla A; Putcha G; Poulos E; Shearer WT
J Immunol; 1993 Jul; 151(2):637-48. PubMed ID: 8393037
[TBL] [Abstract][Full Text] [Related]
9. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
James-Kracke MR; Sexe RB; Shukla SD
J Pharmacol Exp Ther; 1994 Nov; 271(2):824-31. PubMed ID: 7965802
[TBL] [Abstract][Full Text] [Related]
10. Measurement of IP3 mass as a monitor of phospholipase C activation in stimulated human platelets.
Rittenhouse SE; Sasson JP
Nouv Rev Fr Hematol (1978); 1985; 27(4):239-42. PubMed ID: 3877271
[TBL] [Abstract][Full Text] [Related]
11. Lack of constitutive activation or inactivation of the platelet-activating factor receptor by glutamate substitution of alanine 230.
Carlson SA; Chatterjee TK; Fisher RA
Recept Signal Transduct; 1996; 6(2):111-20. PubMed ID: 9015866
[TBL] [Abstract][Full Text] [Related]
12. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
Hwang SB; Lam MH; Hsu AH
Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
[TBL] [Abstract][Full Text] [Related]
13. Platelet activating factor receptor occupancy in relation to activation and desensitization of phosphoinositide specific phospholipase C.
Shukla SD; Morrison WJ
Prog Clin Biol Res; 1988; 283():341-4. PubMed ID: 2850576
[No Abstract] [Full Text] [Related]
14. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.
Hwang SB
J Lipid Mediat; 1990; 2(3-4):123-58. PubMed ID: 1966805
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C is not involved in the desensitization of platelet activating factor receptor in rabbit platelets.
Chau LY
Lipids; 1991 Dec; 26(12):1076-9. PubMed ID: 1668108
[TBL] [Abstract][Full Text] [Related]
16. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
Ortega MP; García MC; Gijón MA; de Casa-Juana MF; Priego JG; Sanchez Crespo M; Sunkel C
J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
[TBL] [Abstract][Full Text] [Related]
17. Staurosporine potentiates platelet activating factor stimulated phospholipase C activity in rabbit platelets but does not block desensitization by platelet activating factor.
Morrison WJ; Dhar A; Shukla SD
Life Sci; 1989; 45(4):333-9. PubMed ID: 2761347
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
19. Natural 1-O-alkylglycerols reduce platelet-activating factor-induced release of [3H]-serotonin in rabbit platelets.
Pédrono F; Cheminade C; Legrand AB
Prostaglandins Leukot Essent Fatty Acids; 2004 Jul; 71(1):19-23. PubMed ID: 15172680
[TBL] [Abstract][Full Text] [Related]
20. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
